CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON) has a 10-report earnings history dating back to May 09, 2024. Its average absolute post-earnings move is ±4.66%, and 60.0% of those reactions were positive. Its largest post-earnings gain was +8.61% (Nov 14, 2025) and its largest decline was -7.43% (May 09, 2024). The next earnings report is predicted for 2026-11-13 (estimated).
Earnings reactions
How CGON moved on each past earnings report.
Earnings Impact
Total Earnings
10
Avg Abs. Movement
±4.66%
Positive %
60.0%
Negative %
40.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☀ PRE | +3.34% | open_in_new |
| May 08, 2026 | ☀ PRE | +0.74% | open_in_new |
| Feb 27, 2026 | ☀ PRE | +4.79% | open_in_new |
| Nov 14, 2025 | ☀ PRE | +8.61% | open_in_new |
Earnings Count
10
Total earnings in dataset
Avg Abs. Movement
±4.66%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260902 | open_in_new SEC.gov |
| 144 | 20260831 | open_in_new SEC.gov |
| 144 | 20260827 | open_in_new SEC.gov |
| 144 | 20260825 | open_in_new SEC.gov |
| 144 | 20260824 | open_in_new SEC.gov |
| 144 | 20260819 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
| 144 | 20260817 | open_in_new SEC.gov |
| 144 | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
Frequently asked about CGON earnings
When does CG Oncology, Inc. report earnings next? expand_more
CG Oncology, Inc. (CGON)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CGON stock move after earnings? expand_more
Over 10 reports, CGON has moved an average of ±4.66% the session after earnings, closing higher 60.0% of the time.
What was CGON's biggest post-earnings move? expand_more
CGON's largest post-earnings gain on record was +8.61% on Nov 14, 2025, and its largest decline was -7.43% on May 09, 2024.
Where can I find CG Oncology, Inc.'s SEC filings? expand_more
All of CG Oncology, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right